The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Mucormycosis (pulmonary, tracheobronchial or systemic)
Publications
Report of 12 cases with tracheobronchial mucormycosis and a review.
The clinical respiratory journal 2018 Apr;12;1651-1660 — 2018 Apr — 1651-1660
Montagna MT, Lovero G, Coretti C, Martinelli D, Delia M, De Giglio O, Caira M, Puntillo F, D'Antonio D, Venditti M, Sambri V, Di Bernardo F, Barbui A, Lo Cascio G, Concia E, Mikulska M, Viscoli C, Maximova N, Candoni A, Oliveri S, Lombardi G, Pitzurra L,
SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients.
Infection 2014 Feb;42;141-51 — 2014 Feb — 141-51
Pulmonary mucormycosis.
Seminars in respiratory and critical care medicine 2011 Dec;32;693-702 — 2011 Dec — 693-702